Targeted solutions to increase dolutegravir coverage, viral load testing coverage, and viral suppression among children living with HIV in Togo: An analysis of routine facility data
Table 2
Demographic, clinical, and immunological characteristics of CLHIV ages 0–14 years currently on treatment, at baseline and endline.